692 research outputs found
Utilisation d'un algorithme génétique pour la composition de services Web
L'architecture orientée services (SOA) est une évolution architecturale des systèmes d'informations qui formalise le concept d'échange et de partage inter-application. L'approche SOA utilise un annuaire de services (UDDI) qui joue un rôle de médiateur entre le fournisseur et le consommateur de services. Le fournisseur ou le producteur de services enregistre la description de son service et, par la suite, le consommateur va interroger l'annuaire afin de trouver un service approprié à ses besoins à partir des descriptions publiées. Une mise en oeuvre possible de cette architecture consiste à utiliser le Web comme support pour la communication entre services. Une telle architecture entraîne donc que les services soient exposés sur le web, qu'on appelle services Web. L'avantage de cette approche est, d'une part, de créer un bassin de clientèle pour les fournisseurs et, d'autre part, de mettre en place une base de services importante à l'attention des consommateurs. Un problème qui apparaît à la mise en oeuvre de cette architecture basée sur les services Web est que le processus de découverte devient assez complexe, et ce en raison de la multitude de services offerts sur Internet, de l'absence d'un standard de représentation des requêtes des consommateurs et en l'absence d'un moteur de recherche efficace. Notre travail consiste à développer une application basée sur les techniques des algorithmes génétiques pour la découverte et la composition de services Web. Le consommateur exprime le service Web désiré par un fichier de description WSDL. Le système interroge un espace de recherche sous la forme de collection de services Web et donne comme résultat une liste de services possibles (population). Le critère de sélection d'un service est sa valeur de similarité avec le service cible. Les éléments de la population résultat sont des services qui existent dans l'espace de recherche (découverte d'un service approprié) ou qui ont été créés par le biais de la composition de services existants. Notre choix d'une approche utilisant les algorithmes génétiques s'est fait parce que les opérations\ud
utilisées par un algorithrne génétique -croisement, mutation, sélection -semblaient avoir une grande correspondance avec la composition de services Web. Les quelques tests que nous avons effectués pour évaluer notre approche semblent justifier notre choix de ces techniques. Toutefois, les résultats pourraient être améliorés par l'introduction de notions sémantiques et le temps de réponse pourrait être amélioré par l'utilisation de parallélisme dans nos algorithmes génétiques. ______________________________________________________________________________ MOTS-CLÉS DE L’AUTEUR : Services Web, Composition de services, Architecture orientée services (SOA), Web Services Description Language (WSDL), Simple Object Access Protocol (SOAP), Algorithmes génétiques
Recommended from our members
Succinate metabolism: a new therapeutic target for myocardial reperfusion injury.
Myocardial ischaemia/reperfusion (IR) injury is a major cause of death worldwide and remains a disease for which current clinical therapies are strikingly deficient. While the production of mitochondrial reactive oxygen species (ROS) is a critical driver of tissue damage upon reperfusion, the precise mechanisms underlying ROS production have remained elusive. More recently, it has been demonstrated that a specific metabolic mechanism occurs during ischaemia that underlies elevated ROS at reperfusion, suggesting a unifying model as to why so many different compounds have been found to be cardioprotective against IR injury. This review will discuss the role of the citric acid cycle intermediate succinate in IR pathology focusing on the mechanism by which this metabolite accumulates during ischaemia and how it can drive ROS production at Complex I via reverse electron transport. We will then examine the potential for manipulating succinate accumulation and metabolism during IR injury in order to protect the heart against IR damage and discuss targets for novel therapeutics designed to reduce reperfusion injury in patients
Recommended from our members
H+ transport is an integral function of the mitochondrial ADP/ATP carrier.
The mitochondrial ADP/ATP carrier (AAC) is a major transport protein of the inner mitochondrial membrane. It exchanges mitochondrial ATP for cytosolic ADP and controls cellular production of ATP. In addition, it has been proposed that AAC mediates mitochondrial uncoupling, but it has proven difficult to demonstrate this function or to elucidate its mechanisms. Here we record AAC currents directly from inner mitochondrial membranes from various mouse tissues and identify two distinct transport modes: ADP/ATP exchange and H+ transport. The AAC-mediated H+ current requires free fatty acids and resembles the H+ leak via the thermogenic uncoupling protein 1 found in brown fat. The ADP/ATP exchange via AAC negatively regulates the H+ leak, but does not completely inhibit it. This suggests that the H+ leak and mitochondrial uncoupling could be dynamically controlled by cellular ATP demand and the rate of ADP/ATP exchange. By mediating two distinct transport modes, ADP/ATP exchange and H+ leak, AAC connects coupled (ATP production) and uncoupled (thermogenesis) energy conversion in mitochondria
Moving Forwards by Blocking Back-Flow: The Yin and Yang of MI Therapy.
Mitochondrial reactive oxygen species production has emerged as an important pathological mechanism in myocardial ischemia/reperfusion injury. Attempts at targeting reactive oxygen species by scavenging using antioxidants have, however, been clinically disappointing. This review will provide an overview of the current understanding of mitochondrial reactive oxygen species in ischemia/reperfusion injury. We will outline novel therapeutic approaches designed to directly target the mitochondrial respiratory chain and prevent excessive reactive oxygen species production and its associated pathology. This approach could lead to more effective interventions in an area where there is an urgent need for new treatments.Work in our laboratories is supported by the Medical Research Council (UK) and the British Heart Foundation.This is the author accepted manuscript. The final version is available from the American Heart Association via http://dx.doi.org/10.1161/CIRCRESAHA.115.30656
Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts.
AIMS: Recently it has been shown that the mitochondria-targeted S-nitrosothiol MitoSNO protects against acute ischaemia/reperfusion (IR) injury by inhibiting the reactivation of mitochondrial complex I in the first minutes of reperfusion of ischaemic tissue, thereby preventing free radical formation that underlies IR injury. However, it remains unclear how this transient inhibition of mitochondrial complex I-mediated free radicals at reperfusion affects the long-term recovery of the heart following IR injury. Here we determined whether the acute protection by MitoSNO at reperfusion prevented the subsequent development of post-myocardial infarction heart failure. METHODS AND RESULTS: Mice were subjected to 30 min left coronary artery occlusion followed by reperfusion and recovery over 28 days. MitoSNO (100 ng/kg) was applied 5 min before the onset of reperfusion followed by 20 min infusion (1 ng/kg/min). Infarct size and cardiac function were measured by magnetic resonance imaging (MRI) 24 h after infarction. MitoSNO-treated mice exhibited reduced infarct size and preserved function. In addition, MitoSNO at reperfusion improved outcome measures 28 days post-IR, including preserved systolic function (63.7 ±1.8% LVEF vs. 53.7 ± 2.1% in controls, P = 0.01) and tissue fibrosis. CONCLUSIONS: MitoSNO action acutely at reperfusion reduces infarct size and protects from post-myocardial infarction heart failure. Therefore, targeted inhibition of mitochondrial complex I in the first minutes of reperfusion by MitoSNO is a rational therapeutic strategy for preventing subsequent heart failure in patients undergoing IR injury
Cefotaxime and ceftazidime-resistant <i>Escherichia coli</i> isolate producing TEM-15 β-lactamase from a Tunisian hospital
Complex I deficiency due to selective loss of Ndufs4 in the mouse heart results in severe hypertrophic cardiomyopathy.
Mitochondrial complex I, the primary entry point for electrons into the mitochondrial respiratory chain, is both critical for aerobic respiration and a major source of reactive oxygen species. In the heart, chronic dysfunction driving cardiomyopathy is frequently associated with decreased complex I activity, from both genetic and environmental causes. To examine the functional relationship between complex I disruption and cardiac dysfunction we used an established mouse model of mild and chronic complex I inhibition through heart-specific Ndufs4 gene ablation. Heart-specific Ndufs4-null mice had a decrease of ∼ 50% in complex I activity within the heart, and developed severe hypertrophic cardiomyopathy as assessed by magnetic resonance imaging. The decrease in complex I activity, and associated cardiac dysfunction, occurred absent an increase in mitochondrial hydrogen peroxide levels in vivo, accumulation of markers of oxidative damage, induction of apoptosis, or tissue fibrosis. Taken together, these results indicate that diminished complex I activity in the heart alone is sufficient to drive hypertrophic cardiomyopathy independently of alterations in levels of mitochondrial hydrogen peroxide or oxidative damage
Using exomarkers to assess mitochondrial reactive species in vivo
Background:
The ability to measure the concentrations of small damaging and signalling molecules such as reactive oxygen species (ROS) in vivo is essential to understanding their biological roles. While a range of methods can be applied to in vitro systems, measuring the levels and relative changes in reactive species in vivo is challenging.
Scope of review:
One approach towards achieving this goal is the use of exomarkers. In this, exogenous probe compounds are administered to the intact organism and are then transformed by the reactive molecules in vivo to produce a diagnostic exomarker. The exomarker and the precursor probe can be analysed ex vivo to infer the identity and amounts of the reactive species present in vivo. This is akin to the measurement of biomarkers produced by the interaction of reactive species with endogenous biomolecules.
Major conclusions and general significance:
Our laboratories have developed mitochondria-targeted probes that generate exomarkers that can be analysed ex vivo by mass spectrometry to assess levels of reactive species within mitochondria in vivo. We have used one of these compounds, MitoB, to infer the levels of mitochondrial hydrogen peroxide within flies and mice. Here we describe the development of MitoB and expand on this example to discuss how better probes and exomarkers can be developed. This article is part of a Special Issue entitled Current methods to study reactive oxygen species - pros and cons and biophysics of membrane proteins. Guest Editor: Christine Winterbourn.
Abbreviations:
EPR, electron paramagnetic resonance; GFP, green fluorescent protein; 4-HNE, 4-hydroxynonenal; MitoB, 3-(dihydroxyboronyl)benzyltriphenylphosphonium bromide; MitoP, (3-hydroxybenzyl)triphenylphosphonium bromide; ROS, reactive oxygen species; SOD, superoxide dismutase; TPMP, methyltriphenylphosphonium; TPP, triphenylphosphonium catio
- …